The incidence and prevalence of diabetes in patients with serious mental illness in North West Wales: Two cohorts, 1875-1924 & 1994-2006 compared

BMC Psychiatry

Volumn 8, Issue , 2008, Pages

  Le Noury, Joanna ^a   Khan, Afshan ^a   Harris, Margaret ^a   Wong, Winnie ^a   Williams, Dawn ^a   Roberts, Tony ^a   Tranter, Richard ^a   Healy, David ^b  

^a North West Wales NHS Trust ^*  (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; CONTROLLED STUDY; DELUSIONAL DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; MENTAL HOSPITAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PSYCHOSIS; SCHIZOPHRENIA; UNITED KINGDOM; ADOLESCENT; ADULT; AGED; CHILD; COMPARATIVE STUDY; DIABETES MELLITUS; HISTORY; HOSPITALIZATION; MIDDLE AGED; RESIDENTIAL CARE;

ADOLESCENT; ADULT; AGED; CATCHMENT AREA (HEALTH); CHILD; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; WALES;

EID: 50149101319     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-8-67     Document Type: Article

References (24)

1. Serynak MJ Leslie DL Alarcon RD Losonczy MF Rosenheck RA Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia Am J Psychiatry 2002, 159:561-566 10.1176/ appi.ajp.159.4.561 11925293
2. Goff DC Sullivan LM McEvoy JP Meyer JM Nasrallah HA Daumit GL Lamberti S D'Agostino RB Stroup TS Davis S Lieberman JA A comparison of ten year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls Schizophrenia Res 2005, 80:45-53 10.1016/ j.schres.2005.08.010
3. Holt RI Bushe C Citrome L Diabetes and schizophrenia 2005: Are we any closer to understanding the link J Psychopharmacology 2005, 19:S56-S65 10.1177/0269881105058379
4. De Hert M van Winkel R Van Eyck D Hanssens L Wampers M Scheen A Peuskens J Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: A cross-sectional study Clin Pract Epidemol Ment Health 2006, 2:14 1533826 16803620 10.1186/ 1745-0179-2-14
5. Kenny SJ Aubert RE Geiss LS Prevalence and incidence of non-insulin-dependent diabetes Diabetes in America Washington D.C, US Government Printing Office Harris M, Cowie C, Reiber G, Boyko E, Stern M, Bennett P 1995:47-68
6. QMAS The NHS Information Centre Prescribing Support Unit. Information Centre Quality Outcomes Framework Data 2005/06. Diabetes Indicators 19 http://www.ic.nhs.uk/webfiles/publications/qof/ NationalQualityOutcomesFramework280906_PDF.pdf
7. Healy D Savage M Michael P Harris M Hirst D Carter M Cattell D McMonagle T Sohler N Susser E Psychiatric bed utilisation: 1896 and 1996 compared Psychol Med 2001, 31:779-790 10.1017/S0033291701003968 11459376
8. Citrome L Jaffe A Levine J Allingham B Robinson J Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients Psychiatric Services 2004, 55:1006-013 10.1176/ appi.ps.55.9.1006 15345760
9. Leslie DL Rosenheck RA Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications Am J Psychiatry 2004, 161:1709-1711 10.1176/appi.ajp.161.9.1709 15337666
10. Arranz B Rosel P Ramirez N Duenas R Fernandez P Sanchez JM Navarro MA San L Insulin resistance and increased leptin concentrations in non-compliant schizophrenia patients but not in antipsychotic naïve first episode schizophrenia patients J Clinical Psychiatry 2004, 65:1335-1342
11. Zhang ZJ Yao ZJ Liu W Fang Q Reynolds GP Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia Brit J Psychiatry 2004, 184:58-62 10.1192/bjp.184.1.58
12. Kooy FH Hyperglycemia in mental disorders Brain 1919, 42:214-289 10.1093/ brain/42.3.214
13. Drury KK Farron-Ridge C Some observations of the types of blood-sugar curves found in different forms of insanity J Ment Sci 1925, 71:8-29
14. Raphael T Parsons JP Blood sugar studies in dementia praecox and manic-depressive insanity Arch Neurology & Psychiatry 1921, 5:687-709
15. Lorenz WF Sugar tolerance in dementia praecox and other mental states Arch Neurology & Psychiatry 1922, 8:184-196
16. Barrett TB Serre P Blood analysis and sugar tolerance in mental disease J Nerv & Ment Disease 1924, 59:561-570 10.1097/ 00005053-192406000-00001
17. Kasanin J The blood sugar curve in mental disease. II. The schizophrenia (dementia praecox) groups Arch Neurology & Psychiatry 1926, 16:414-419
18. Courvoisier S Fournel J Ducrot R Pharmacodynamic properties of 3-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride (R.P. 4560); experimental study of a new substance used in potentialized anesthesia and in artificial hibernation Arch Int Pharmacodynamic Therapy 1953, 92:305-361
19. Dobkin AB Lamoureux L Letienne R Some studies with Largactil Can Med Assoc J 1954, 70:626-628 1825408 13160900
20. Giacobini E Lassenius B Chlorpromazine treatment; side effects and complications Nordic Medicine 1954, 52:1693-1699
21. Merivale WH Hunter RA Abnormal glucose tolerance tests in patients treated with sedative drugs Lancet 1954, ii:939-942 10.1016/ S0140-6736(54)92554-4
22. Charatan FBE Bartlett NG The effect of chlorpromazine ('Largactil') on glucose tolerance J Ment Sci 1955, 101:351-353 13243049
23. Hiles BW Hyperglycemia and glycosuria following chlorpromazine therapy JAMA 1956, 62:1651
24. Eaton WW Byrne M Ewald H Mors O Chen C-Y Agerbo E Mortensen PB Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers Am J Psychiatry 2006, 163:521-528 10.1176/ appi.ajp.163.3.521 16513876